DANAE WALKER: Open Payments
NPI 1619659968 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 68 payments from 16 companies in 2025. Trend: 2023 $184 · 2024 $1,349 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $300 |
| Amgen Inc. | 14 | $145 |
| Lundbeck LLC | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Novo Nordisk Inc | 4 | $71 |
| Lilly USA, LLC | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 4 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
Products named: REXULTI, QULIPTA, VRAYLAR, FANAPT, OTEZLA, MOUNJARO, GEMTESA, VOQUEZNA.
Industry payments across ID — which companies pay providers there.
